...
首页> 外文期刊>Thoracic cancer. >Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
【24h】

Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases

机译:同步多发性食管癌的特征和预后因素:附52例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Background: To retrospectively analyze the clinical characteristics and prognostic factors of 52 cases of synchronous multiple primary esophageal carcinoma (SMPEC), in order to provide a reference for treatment strategy. Methods: Clinical and survival data of 52 patients with SMPEC were analyzed retrospectively. The rates of overall survival (OS), depending on the different factors, were calculated using Kaplan-Meier analysis. A log-rank test was used for univariate survival analysis and Cox's proportional hazards regression model was used for multivariate survival analysis. Results: Clinical and survival data of 52 patients with SMPEC, hospitalized from 1 January 2003 to 31 October 2011, were analyzed. Twelve patients underwent surgical resection, five received adjuvant radiotherapy and one received adjuvant radiochemotherapy. Thirty-seven of the 40 non-operative patients received external beam radiation therapy and 20 of them received platinum-based chemotherapy. Another three non-operative patients were given platinum-based chemotherapy alone. The one, three, and five-year OS and the median survival time (MST) were 65.4%, 17.3%, 7.7%, respectively, and 15.0 months for the whole cohort. Tumor length and M stage were independent prognostic factors for the whole cohort by multivariate survival analysis (P = 0.010 and 0.047, respectively). For the radiotherapy subgroup, multivariate analysis of prognostic factors identified that shorter tumor length, M0 stage, and chemotherapy were the predominant independent predictors of long-term survival (P = 0.039, 0.022 and 0.010, respectively). Conclusions: SMPEC is a relatively rare and aggressive tumor. Combined radiotherapy with chemotherapy seemed to bring a survival benefit and may be a better management choice for unresectable and non-operative SMPEC.
机译:背景:回顾性分析52例同步多发性原发性食管癌(SMPEC)的临床特点和预后,为治疗策略提供参考。方法:回顾性分析52例SMPEC患者的临床和生存资料。使用Kaplan-Meier分析计算总生存率(OS),具体取决于不同因素。对数秩检验用于单变量生存分析,而Cox比例风险回归模型用于多变量生存分析。结果:分析了2003年1月1日至2011年10月31日住院的52例SMPEC患者的临床和生存数据。 12例患者接受了手术切除,其中5例接受了辅助放疗,另一例接受了辅助放化疗。 40名非手术患者中有37名接受了外部束放射疗法,其中20名接受了铂类化学疗法。另外三名非手术患者仅接受铂类化疗。整个队列的一年,三年和五年OS和中位生存时间(MST)分别为65.4%,17.3%,7.7%和15.0个月。通过多因素生存分析,肿瘤长度和M分期是整个队列的独立预后因素(分别为P = 0.010和0.047)。对于放疗亚组,对预后因素进行多因素分析,发现较短的肿瘤长度,M0分期和化疗是长期生存的主要独立预测因素(分别为P = 0.039、0.022和0.010)。结论:SMPEC是一种相对罕见的侵袭性肿瘤。放射疗法与化学疗法的结合似乎可以带来生存益处,并且对于无法切除和非手术的SMPEC可能是更好的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号